fashion -WSS

fashion

author：hotspot 2025-09-29 22:47:26 - browse：744

A vial of Tofersen injection on the left of its box — The ALS drug tofersen is marketed as Qalsody in the U.S. Biogen

LONDON — Neurologists and patient advocates are up in arms over a policy decision by a U.K. health agency that they say will imperil access to an ALS treatment that’s available in the U.S. and on its way to approval in the European Union.

The medicine in question, Biogen’s tofersen, is designed to treat a rare genetic form of the neurodegenerative disease, accounting for some 2% of all ALS cases. And the issue is how the U.K.’s cost-effectiveness agency has said it would assess the costs and benefits of the therapy.

The agency, the National Institute for Health and Care Excellence, or NICE, has a special pathway for drugs for very rare diseases, which advocates and doctors argue is the route through which tofersen should be reviewed. But NICE has indicated it would review the drug through its standard process, saying it’s because ALS as a whole does not count as a “very rare” disease. That sets a higher bar to clear.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： How AI helped researchers track recovery from depression

WSS

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

Why Marc Tessier

Why Marc Tessier

Senate HELP committee spars over health care workforce policies

FDA panel to weigh approval of NurOwn, controversial ALS drug

Ukraine and a new approach to mental health in war

leisure time

fashion

leisure time

As demand for Covid shots wanes, Moderna seeks its next success

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

At least 13 dead in Texas as scorching temps continue

Senators: Long

Activists slam private health insurers over coverage restrictions

Lasker Awards 2023: Winners in biomedical research

Wildfire smoke exposes gaps in outdoor worker protections

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Heart attack and stroke risk calculators need revising

CommonSpirit Health keeps growing, even as it loses money

leisure time

CDC advisers recommend seasonal use of Pfizer RSV shot

Senators: Long

How Vertex's cystic fibrosis drug is changing patients' lives

Senate HELP committee spars over health care workforce policies

Microbiome research is starting to find links to chronic diseases

Senate HELP committee spars over health care workforce policies

knowledge

hotspot

explore

explore